CLRB Past Earnings image Cellectar Biosciences Past Earnings

CLRB Past Earnings

— Presenting past earnings and revenue for Cellectar Biosciences (CLRB) from Q1 2014 to Q2 2026, based on our latest update on 8/19/2026. The past earnings numbers are per-share values while the revenue is the grand total for the quarter. Studying these CLRB past earnings numbers both in chart format and in tables can help investors visualize any typical seasonality patterns, as well as determine whether the company has grown over time.
Quick links: Past Earnings  |  Past Revenue  |  FAQ
CLRB Past Earnings
PeriodPast Earnings DateGAAP
Q2 20268/13/2026-0.570
Q1 20265/14/2026-1.330
Q4 20253/4/2026-0.530
Q3 202511/13/2025-1.410
Q2 20258/14/2025-3.390
Q1 20255/13/2025-4.200
Q4 20243/13/2025-0.300
Q3 202411/18/2024-12.000
Q2 202410/29/2024-5.400
Q1 20245/14/2024-22.200
Q4 20233/27/2024-12.000
Q3 202311/13/2023-24.600
Q2 20238/14/2023-21.900
Q1 20235/4/2023-22.800
Q4 20223/9/2023-16.500
Q3 202211/3/2022-38.400
Q2 20228/5/2022-36.600
Q1 20225/10/2022-30.000
Q4 20213/21/2022-27.000
Q3 202111/8/2021-30.000
Q2 20218/9/2021-33.000
Q1 20215/10/2021-39.000
Q4 20203/2/2021-18.000
Q3 202011/9/2020-45.000
Q2 20208/10/2020-78.000
Q1 20205/7/2020-126.000
Q4 20193/9/2020-99.000
Q3 201911/12/2019-126.000
Q2 20198/12/2019-138.000
Q1 20195/6/2019-228.000
Q4 20182/26/201918.000
Q3 201811/13/2018-495.000
Q2 20188/10/2018-507.000
Q1 20185/11/2018-630.000
Q4 20173/21/2018-1020.000
Q3 201711/9/2017-480.000
Q2 20178/14/2017-690.000
Q1 20175/11/2017-720.000
Q4 20163/15/2017-1020.000
Q3 201611/10/2016-1290.000
Q2 20168/11/2016-1470.000
Q1 20165/12/20162730.000
Q4 20153/10/2016-18540.000
Q3 201511/12/2015-7500.000
Q2 20158/12/2015-9000.000
Q1 20155/21/2015-9000.000
Q4 20143/24/2015-16800.000
Q3 201411/11/2014-3000.000
Q2 20148/20/2014-21900.000
Q1 20145/14/2014-30000.000
CLRB Past Revenue
PeriodPast Earnings DateGAAP
Q2 20268/13/2026NA
Q1 20265/14/2026NA
Q4 20253/4/2026NA
Q3 202511/13/2025NA
Q2 20258/14/2025NA
Q1 20255/13/2025NA
Q4 20243/13/2025NA
Q3 202411/18/2024NA
Q2 202410/29/2024NA
Q1 20245/14/2024NA
Q4 20233/27/2024NA
Q3 202311/13/2023NA
Q2 20238/14/2023NA
Q1 20235/4/2023NA
Q4 20223/9/2023NA
Q3 202211/3/2022NA
Q2 20228/5/2022NA
Q1 20225/10/2022NA
Q4 20213/21/2022NA
Q3 202111/8/2021NA
Q2 20218/9/2021NA
Q1 20215/10/2021NA
Q4 20203/2/2021NA
Q3 202011/9/2020NA
Q2 20208/10/2020NA
Q1 20205/7/2020NA
Q4 20193/9/2020NA
Q3 201911/12/2019NA
Q2 20198/12/2019NA
Q1 20195/6/2019NA
Q4 20182/26/2019NA
Q3 201811/13/2018NA
Q2 20188/10/2018NA
Q1 20185/11/2018NA
Q4 20173/21/2018NA
Q3 201711/9/2017NA
Q2 20178/14/2017NA
Q1 20175/11/2017NA
Q4 20163/15/2017NA
Q3 201611/10/2016NA
Q2 20168/11/2016NA
Q1 20165/12/2016NA
Q4 20153/10/2016NA
Q3 201511/12/2015NA
Q2 20158/12/2015NA
Q1 20155/21/2015NA
Q4 20143/24/2015NA
Q3 201411/11/2014NA
Q2 20148/20/2014NA
Q1 20145/14/2014NA
Quotes delayed 20 minutes

Email EnvelopeFree CLRB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cellectar Biosciences (CLRB) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CLSD Past Earnings
CLSN Past Earnings
CLVS Past Earnings
CLXT Past Earnings
CLYM Past Earnings
CMAX Past Earnings
CMD Past Earnings
CMPI Past Earnings
CMPX Past Earnings
CMRX Past Earnings

CLRB Past Earnings Q&A

What was the best and worst CLRB past earnings results?
For Cellectar Biosciences, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest CLRB past earnings result in our data set was 2730.000/share posted in Q1 2016, while the lowest was in Q1 2014 when CLRB posted -30000.000/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2026 when CLRB reported NA in revenue, while the quarter with the lowest revenue in our data set was Q2 2026 at NA of revenue.

  Suggested answer: There are 50 CLRB past earnings results in our data set.

On this page we presented the CLRB past earnings date information for Cellectar Biosciences. Reviewing that CLRB Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2016, when CLRB posted gaap of 2730.000/share. Meanwhile the lowest CLRB past earnings result was in Q1 2014, when CLRB posted gaap of -30000.000/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2026 when CLRB reported NA in revenue, while the smallest revenue quarter was Q2 2026 when CLRB reported NA in revenue.

Any self directed investor doing their due diligence on CLRB or any other given stock can benefit from researching all of the Cellectar Biosciences past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Cellectar Biosciences past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CLRB. Thanks for visiting, and the next time you need to research CLRB past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.
 

CLRB Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2026, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.